Page last updated: 2024-11-05

estragole

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Estragole, also known as methyl chavicol, is a naturally occurring phenylpropene found in various plants, notably basil, tarragon, and fennel. It possesses a sweet, anise-like aroma and is commonly used as a flavoring agent. Research has focused on estragole due to its potential biological activities, including its antifungal and anti-inflammatory properties. However, studies have also raised concerns about its potential toxicity, particularly its carcinogenic effects in animal models. The synthesis of estragole involves the methylation of chavicol, a phenolic compound. The compound's importance lies in its role in plant defense mechanisms and its utilization in the food and fragrance industries. Further research is needed to elucidate its complex pharmacological effects and determine its safety profile for human consumption.'

estragole : A phenylpropanoid that is chavicol in which the hydroxy group is replaced by a methoxy group. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID8815
CHEMBL ID470671
CHEBI ID4867
SCHEMBL ID57204
MeSH IDM0050940

Synonyms (118)

Synonym
nci-c60946
nsc 404113
ccris 1317
estragole (natural)
einecs 205-427-8
fema number 2411
brn 1099454
1-methoxy-4-(2-propen-1-yl)benzene
p-allylmethoxybenzene
epa pesticide chemical code 062150
hsdb 5412
allylphenyl methyl ether, p-
chavicyl methyl ether
fema no. 2411
ai3-16052
benzene, 1-methoxy-4-(2-propenyl)-
inchi=1/c10h12o/c1-3-4-9-5-7-10(11-2)8-6-9/h3,5-8h,1,4h2,2h
benzene,1-allyl,4-methoxy methylchavicol
1-allyl-4-methoxybenzene
4-allyl-1-methoxybenzene
wln: 1u2r do1
methyl chavicol
3-(p-methoxyphenyl)propene
p-allylanisole
esdragon
nsc404113
estragol
anisole, p-allyl-
chavicol methyl ether
esdragole
esdragol
4-allylanisole
4-methoxyallylbenzene
4-allylmethoxybenzene
nsc-404113
chavicol, o-methyl-
terragon
tarragon
isoanethole
p-methoxyallylbenzene
NCGC00091434-01
smr000112379
MLS001065575
1-methoxy-4-(2-propenyl)benzene
estragole
methylchavicol
140-67-0
4-allylanisole, >=98%, fcc
4-allylanisole, 98%
NCGC00091434-02
SPECTRUM1505117
A0702
1-methoxy-4-prop-2-enylbenzene
chebi:4867 ,
CHEMBL470671
esteragol
AKOS000121300
NCGC00091434-03
tox21_302930
dtxcid40575
NCGC00256481-01
cas-140-67-0
dtxsid0020575 ,
tox21_202387
NCGC00259936-01
HMS2268E24
benzene, 1-methoxy-4-(2-propen-1-yl)-
unii-9niw07v3et
9niw07v3et ,
4-06-00-03817 (beilstein handbook reference)
FT-0617414
1-allyl-4-methoxy-benzene
1-methoxy-4-(2-propenyl)-benzene
estragole [mi]
1-methoxy-4-(2-propenyl)benzene [hsdb]
estragole [fcc]
estragole [fhfi]
austl 21320
S5339 ,
CCG-214642
SCHEMBL57204
4-allylanisol
3-(4-methoxyphenyl)-1-propene
para-allylanisole
chavicol, methyl-
p-allylphenyl methyl ether
methyl chavicole
benzene, 1-methoxy, 4-prop-2-enyl
ether, p-allylphenyl methyl
mfcd00008653
1-methoxy-4-(prop-2-en-1-yl)benzene
sr-01000838348
SR-01000838348-2
estragole, analytical standard
4-allylanisole, analytical standard
4-allylanisole, purum, >=97.0% (gc)
1-methoxy-4-(2-propenyl)benzene, 9ci
p-allyl-anisole
estragol (methylchavicol)
o-methyl-chavicol
isoanthethole
fema 2411
1-methoxy-4-(2-propen-1-yl)-benzene
para-allylanisole (estragole)
methyl-chavicol
benzene,1-allyl,4-methoxy methylchavicol
methyl chavicole (estragole)
J-007415
77525-18-9
1407-27-8
Q419495
AS-35303
4-methoxy allylbenzene
p-methoxy allylbenzene
HY-N5060
CS-0032231
1 -methoxy-4-(2-propenyl) benzene
EN300-21676

Research Excerpts

Overview

Estragole is an aromatic organic compound belonging to the class of phenylpropanoids derived from cinnamic aldehydes. It is present in essential oils of plant species, such asRavensara anisata (madeira), Ocimum basilicum (manjericão/alfavaca) and Croton zehntneri (canelinha) Estragoles is a known hepatocarcinogen in rodents at high doses.

ExcerptReferenceRelevance
"Estragole is an aromatic organic compound belonging to the class of phenylpropanoids derived from cinnamic aldehydes and present in essential oils of plant species, such asRavensara anisata (madeira), Ocimum basilicum (manjericão/alfavaca) and Croton zehntneri (canelinha). "( Estragole prevents gastric ulcers via cytoprotective, antioxidant and immunoregulatory mechanisms in animal models.
Alves Júnior, EB; Araújo, AA; Batista, LM; Cristina Araruna, ME; de Araujo Junior, RF; de Carvalho, TG; de Jesus, TG; de Lima Serafim, CA; de Oliveira Formiga, R; de Souza Pessoa, ML; Sobral, MV; Vasconcelos, RC; Vieira, GC, 2020
)
3.44
"Estragole is a known hepatocarcinogen in rodents at high doses following metabolic conversion to the DNA-reactive metabolite 1'-sulfooxyestragole. "( Evaluation of Interindividual Human Variation in Bioactivation and DNA Adduct Formation of Estragole in Liver Predicted by Physiologically Based Kinetic/Dynamic and Monte Carlo Modeling.
Paini, A; Punt, A; Rietjens, IM; Schilter, B; Scholz, G; Spenkelink, A; van Bladeren, PJ, 2016
)
2.1
"Estragole is a natural constituent of several herbs and spices including sweet basil. "( Identification of nevadensin as an important herb-based constituent inhibiting estragole bioactivation and physiology-based biokinetic modeling of its possible in vivo effect.
Adams, T; Alhusainy, W; Delatour, T; Louisse, J; Paini, A; Punt, A; Rietjens, IM; Schilter, B; Scholz, G; Spenkelink, A; van Bladeren, PJ; Vervoort, J, 2010
)
2.03
"Estragole (ES) is a natural constituent of several herbs and spices that acts as a carcinogen in the livers of rodents. "( Detection and quantification of specific DNA adducts by liquid chromatography-tandem mass spectrometry in the livers of rats given estragole at the carcinogenic dose.
Fukuhara, K; Hibi, D; Ishii, Y; Jin, M; Nishikawa, A; Suzuki, Y; Umemura, T, 2011
)
2.02
"Estragole is a natural organic compound that is used as an additive, flavoring agent, or fragrance in a variety of food, cleaning, and cosmetic products; as an herbal medicine; as an antimicrobial agent against acid-tolerant food microflora; and to produce synthetic anise oil. "( NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
Bristol, DW, 2011
)
2.1
"Estragole (ES) is a natural organic compound used frequently as a flavoring food additive. "( Possible involvement of genotoxic mechanisms in estragole-induced hepatocarcinogenesis in rats.
Hibi, D; Inoue, T; Ishii, Y; Jin, M; Nishikawa, A; Nohmi, T; Ogawa, K; Sakai, H; Suzuki, Y; Umemura, T; Yanai, T, 2012
)
2.08
"Estragole is a naturally occurring food-borne genotoxic compound found in a variety of food sources, including spices and herbs. "( In vivo validation of DNA adduct formation by estragole in rats predicted by physiologically based biodynamic modelling.
Alink, G; Gremaud, E; Paini, A; Punt, A; Rietjens, IM; Schilter, B; Scholz, G; Spenkelink, B; van Bladeren, PJ, 2012
)
2.08
"Estragole (ES) is a natural constituent of a number of plants (e.g. "( Constituents of aromatic plants: II. Estragole.
De Vincenzi, M; Maialetti, F; Scazzocchio, B; Silano, M, 2000
)
2.02

Effects

ExcerptReferenceRelevance
"Estragole has been shown to be hepatocarcinogenic in rodent species at high-dose levels. "( A physiologically based biodynamic (PBBD) model for estragole DNA binding in rat liver based on in vitro kinetic data and estragole DNA adduct formation in primary hepatocytes.
Delatour, T; Marin-Kuan, M; Paini, A; Punt, A; Rietjens, IM; Schilter, B; Scholz, G; van Bladeren, PJ; Viton, F, 2010
)
2.05

Actions

Estragole seems to inhibit the glucocorticoid induction of these hepatic enzymes not via the unspecific toxic damage of the liver. Estragol did not produce strand breaks in plasmid DNA in vitro.

ExcerptReferenceRelevance
"Estragole did not produce strand breaks in plasmid DNA in vitro."( Estragole: a weak direct-acting food-borne genotoxin and potential carcinogen.
Cação, R; Cole, KJ; Laires, A; Martins, C; Phillips, DH; Rodrigues, AS; Rueff, J, 2012
)
2.54
"Estragole seems to inhibit the glucocorticoid induction of these hepatic enzymes not via the unspecific toxic damage of the liver."( [Effect of estragole on glucocorticoid induction of tyrosine aminotransferase and tryprophan oxygenase in the rat and mouse liver].
Il'nitskaia, SI; Kaledin, VI; Pakharukova, MIu; Pivovarova, EN; Vasil'eva, ED, 2005
)
1.44

Toxicity

ExcerptReferenceRelevance
" Moreover, the safe use of anise oil is discussed due to potential toxic effects of estragole."( Pimpinella anisum seeds essential oil from Lesvos island: Effect of hydrodistillation time, comparison of its aromatic profile with other samples of the Greek market. Safe use.
Anastasopoulou, E; Calapai, G; Chinou, I; Ganos, C; Graikou, K, 2020
)
0.78
" In the final step, samples and single-aroma standards were tested for their toxicity to HUVEC/Tert2 cells, where some single-flavoring chemicals such as cinnamic aldehyde revealed significant toxic effects."( Quantification of selected aroma compounds in e-cigarette products and toxicity evaluation in HUVEC/Tert2 cells.
Bonn, G; Gstir, R; Noël, JC; Rainer, D; Rainer, M, 2020
)
0.56

Compound-Compound Interactions

ExcerptReferenceRelevance
"The anti-Candida effects of estragole combined with amphotericin B or ketoconazole, commonly used antifungal drugs for treatment of candidasis, were evaluated in this study."( Anti-Candida effects of estragole in combination with ketoconazole or amphotericin B.
Pyun, MS; Shin, S, 2004
)
0.92

Dosage Studied

No DNA damage was detected in stomach, nor was MN elevated in peripheral blood following dosing with safrole. As far both safrole and estragole, oxidative damage may contribute to genotoxicity.

ExcerptRelevanceReference
" The non-linear dose-response curves for genotoxicity obtained with the allylbenzenes and their 1'-hydroxy metabolites indicate that it is important to consider dose-dependence in metabolism when interpreting the significance to humans of animal data obtained with very high doses of the compounds studied."( Comparative induction of unscheduled DNA synthesis in cultured rat hepatocytes by allylbenzenes and their 1'-hydroxy metabolites.
Caldwell, J; Chan, VS, 1992
)
0.28
" All test chemicals acted fast and showed a steep dose-response relationship."( Insecticidal activity of basil oil, trans-anethole, estragole, and linalool to adult fruit flies of Ceratitis capitata, Bactrocera dorsalis, and Bactrocera cucurbitae.
Chang, CL; Cho, IK; Li, QX, 2009
)
0.6
" Dose-related increases in platelet counts occurred in most of the dosed groups of rats; the effect appeared to be stronger in males."( NTP 3-month toxicity studies of estragole (CAS No. 140-67-0) administered by gavage to F344/N rats and B6C3F1 mice.
Bristol, DW, 2011
)
0.65
" The present study demonstrated a direct correlation between tarragon extract dosage and three major outcome variables: MI; serum liver enzyme activity; and liver histopathology."( Toxicological and mutagenic analysis of Artemisia dracunculus (tarragon) extract.
Bombicz, M; Galehdari, H; Gesztelyi, R; Haines, D; Juhasz, B; Kalantari, H; Tosaki, A; Varga, B; Zaree, Z, 2013
)
0.39
"Given the role of the SULT-mediated DNA adduct formation in the hepatocarcinogenicity of estragole, the results of the present study suggest that the likelihood of bioactivation and subsequent adverse effects in rodent bioassays may be lower when estragole is dosed with nevadensin compared to dosing of pure estragole."( In vivo validation and physiologically based biokinetic modeling of the inhibition of SULT-mediated estragole DNA adduct formation in the liver of male Sprague-Dawley rats by the basil flavonoid nevadensin.
Adams, TB; Alhusainy, W; Paini, A; Punt, A; Rietjens, IM; Schilter, B; Scholz, G; Taylor, S; van Bladeren, PJ; van den Berg, JH, 2013
)
0.83
" No DNA damage was detected in stomach, nor was MN elevated in peripheral blood following dosing with safrole suggesting that, as far both safrole and estragole, oxidative damage may contribute to genotoxicity."( In vivo genotoxicity of estragole in male F344 rats.
Bishop, ME; Davis, KJ; Ding, W; Duan, JD; Jeffrey, AM; Levy, DD; Lyn-Cook, LE; Manjanatha, MG; Pearce, MG; White, GA; Williams, GM, 2015
)
0.92
" The dosage of 50 μg/disk of ESL presented fairly significant zones of inhibition against Gram-positive bacteria and fungi."( Isolation, characterization and evaluation of antimicrobial and cytotoxic activity of estragole, obtained from the essential oil of Croton zehntneri (Euphorbiaceae).
Andrade, TC; Da Silva, TG; De Lima, SG; Freitas, RM; Islam, T; Militão, GC; Rocha, MS, 2015
)
0.64
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (5)

RoleDescription
flavouring agentA food additive that is used to added improve the taste or odour of a food.
insect attractantA chemical that attracts insects.
plant metaboliteAny eukaryotic metabolite produced during a metabolic reaction in plants, the kingdom that include flowering plants, conifers and other gymnosperms.
genotoxinA role played by a chemical compound to induce direct or indirect DNA damage. Such damage can potentially lead to the formation of a malignant tumour, but DNA damage does not lead inevitably to the creation of cancerous cells.
carcinogenic agentA role played by a chemical compound which is known to induce a process of carcinogenesis by corrupting normal cellular pathways, leading to the acquistion of tumoral capabilities.
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (3)

ClassDescription
alkenylbenzeneA member of the class of benzenes that is benzene substituted with one or more alkenyl groups. It is a group of naturally occurring compounds that are synthesized as secondary metabolites in various plants, including nutmeg and basil.
monomethoxybenzeneCompounds containing a benzene skeleton substituted with one methoxy group.
phenylpropanoidAny organic aromatic compound with a structure based on a phenylpropane skeleton. The class includes naturally occurring phenylpropanoid esters, flavonoids, anthocyanins, coumarins and many small phenolic molecules as well as their semi-synthetic and synthetic analogues. Phenylpropanoids are also precursors of lignin.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Pathways (1)

PathwayProteinsCompounds
volatile cinnamoic ester biosynthesis016
volatile cinnamoic ester biosynthesis216

Protein Targets (32)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASEHomo sapiens (human)Potency47.44360.003245.467312,589.2998AID2517
15-lipoxygenase, partialHomo sapiens (human)Potency31.62280.012610.691788.5700AID887
TDP1 proteinHomo sapiens (human)Potency14.79580.000811.382244.6684AID686978; AID686979
aldehyde dehydrogenase 1 family, member A1Homo sapiens (human)Potency35.48130.011212.4002100.0000AID1030
thyroid stimulating hormone receptorHomo sapiens (human)Potency12.58930.001318.074339.8107AID926; AID938
estrogen receptor 2 (ER beta)Homo sapiens (human)Potency27.30600.000657.913322,387.1992AID1259377
estrogen nuclear receptor alphaHomo sapiens (human)Potency47.79330.000229.305416,493.5996AID743075; AID743077
67.9K proteinVaccinia virusPotency3.10990.00018.4406100.0000AID720579; AID720580
activating transcription factor 6Homo sapiens (human)Potency61.65240.143427.612159.8106AID1159516
cellular tumor antigen p53 isoform aHomo sapiens (human)Potency0.63100.316212.443531.6228AID924
polyunsaturated fatty acid lipoxygenase ALOX12Homo sapiens (human)Potency11.22021.000012.232631.6228AID1452
chromobox protein homolog 1Homo sapiens (human)Potency89.12510.006026.168889.1251AID540317
survival motor neuron protein isoform dHomo sapiens (human)Potency10.00000.125912.234435.4813AID1458
cytochrome P450 3A4 isoform 1Homo sapiens (human)Potency12.58930.031610.279239.8107AID884; AID885
Gamma-aminobutyric acid receptor subunit piRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Integrin beta-3Homo sapiens (human)Potency0.63100.316211.415731.6228AID924
Integrin alpha-IIbHomo sapiens (human)Potency0.63100.316211.415731.6228AID924
Gamma-aminobutyric acid receptor subunit beta-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit deltaRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-5Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-4Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit gamma-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-6Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-3Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
GABA theta subunitRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
Gamma-aminobutyric acid receptor subunit epsilonRattus norvegicus (Norway rat)Potency12.58931.000012.224831.6228AID885
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Biological Processes (70)

Processvia Protein(s)Taxonomy
negative regulation of low-density lipoprotein receptor activityIntegrin beta-3Homo sapiens (human)
positive regulation of protein phosphorylationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
cell-substrate junction assemblyIntegrin beta-3Homo sapiens (human)
cell adhesionIntegrin beta-3Homo sapiens (human)
cell-matrix adhesionIntegrin beta-3Homo sapiens (human)
integrin-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
embryo implantationIntegrin beta-3Homo sapiens (human)
blood coagulationIntegrin beta-3Homo sapiens (human)
positive regulation of endothelial cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of gene expressionIntegrin beta-3Homo sapiens (human)
negative regulation of macrophage derived foam cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast migrationIntegrin beta-3Homo sapiens (human)
negative regulation of lipid storageIntegrin beta-3Homo sapiens (human)
response to activityIntegrin beta-3Homo sapiens (human)
smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell migrationIntegrin beta-3Homo sapiens (human)
platelet activationIntegrin beta-3Homo sapiens (human)
positive regulation of vascular endothelial growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
cell-substrate adhesionIntegrin beta-3Homo sapiens (human)
activation of protein kinase activityIntegrin beta-3Homo sapiens (human)
negative regulation of lipid transportIntegrin beta-3Homo sapiens (human)
regulation of protein localizationIntegrin beta-3Homo sapiens (human)
regulation of actin cytoskeleton organizationIntegrin beta-3Homo sapiens (human)
cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of cell adhesion mediated by integrinIntegrin beta-3Homo sapiens (human)
positive regulation of osteoblast proliferationIntegrin beta-3Homo sapiens (human)
heterotypic cell-cell adhesionIntegrin beta-3Homo sapiens (human)
substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
tube developmentIntegrin beta-3Homo sapiens (human)
wound healing, spreading of epidermal cellsIntegrin beta-3Homo sapiens (human)
cellular response to platelet-derived growth factor stimulusIntegrin beta-3Homo sapiens (human)
apolipoprotein A-I-mediated signaling pathwayIntegrin beta-3Homo sapiens (human)
wound healingIntegrin beta-3Homo sapiens (human)
apoptotic cell clearanceIntegrin beta-3Homo sapiens (human)
regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
positive regulation of angiogenesisIntegrin beta-3Homo sapiens (human)
positive regulation of bone resorptionIntegrin beta-3Homo sapiens (human)
symbiont entry into host cellIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
positive regulation of fibroblast proliferationIntegrin beta-3Homo sapiens (human)
mesodermal cell differentiationIntegrin beta-3Homo sapiens (human)
positive regulation of smooth muscle cell proliferationIntegrin beta-3Homo sapiens (human)
positive regulation of peptidyl-tyrosine phosphorylationIntegrin beta-3Homo sapiens (human)
negative regulation of lipoprotein metabolic processIntegrin beta-3Homo sapiens (human)
negative chemotaxisIntegrin beta-3Homo sapiens (human)
regulation of release of sequestered calcium ion into cytosolIntegrin beta-3Homo sapiens (human)
regulation of serotonin uptakeIntegrin beta-3Homo sapiens (human)
angiogenesis involved in wound healingIntegrin beta-3Homo sapiens (human)
positive regulation of ERK1 and ERK2 cascadeIntegrin beta-3Homo sapiens (human)
platelet aggregationIntegrin beta-3Homo sapiens (human)
cellular response to mechanical stimulusIntegrin beta-3Homo sapiens (human)
cellular response to xenobiotic stimulusIntegrin beta-3Homo sapiens (human)
positive regulation of glomerular mesangial cell proliferationIntegrin beta-3Homo sapiens (human)
blood coagulation, fibrin clot formationIntegrin beta-3Homo sapiens (human)
maintenance of postsynaptic specialization structureIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor internalizationIntegrin beta-3Homo sapiens (human)
regulation of postsynaptic neurotransmitter receptor diffusion trappingIntegrin beta-3Homo sapiens (human)
positive regulation of substrate adhesion-dependent cell spreadingIntegrin beta-3Homo sapiens (human)
positive regulation of adenylate cyclase-inhibiting opioid receptor signaling pathwayIntegrin beta-3Homo sapiens (human)
regulation of trophoblast cell migrationIntegrin beta-3Homo sapiens (human)
regulation of extracellular matrix organizationIntegrin beta-3Homo sapiens (human)
cellular response to insulin-like growth factor stimulusIntegrin beta-3Homo sapiens (human)
negative regulation of endothelial cell apoptotic processIntegrin beta-3Homo sapiens (human)
positive regulation of T cell migrationIntegrin beta-3Homo sapiens (human)
cell migrationIntegrin beta-3Homo sapiens (human)
positive regulation of leukocyte migrationIntegrin alpha-IIbHomo sapiens (human)
cell-matrix adhesionIntegrin alpha-IIbHomo sapiens (human)
integrin-mediated signaling pathwayIntegrin alpha-IIbHomo sapiens (human)
angiogenesisIntegrin alpha-IIbHomo sapiens (human)
cell-cell adhesionIntegrin alpha-IIbHomo sapiens (human)
cell adhesion mediated by integrinIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Molecular Functions (21)

Processvia Protein(s)Taxonomy
fibroblast growth factor bindingIntegrin beta-3Homo sapiens (human)
C-X3-C chemokine bindingIntegrin beta-3Homo sapiens (human)
insulin-like growth factor I bindingIntegrin beta-3Homo sapiens (human)
neuregulin bindingIntegrin beta-3Homo sapiens (human)
virus receptor activityIntegrin beta-3Homo sapiens (human)
fibronectin bindingIntegrin beta-3Homo sapiens (human)
protease bindingIntegrin beta-3Homo sapiens (human)
protein disulfide isomerase activityIntegrin beta-3Homo sapiens (human)
protein kinase C bindingIntegrin beta-3Homo sapiens (human)
platelet-derived growth factor receptor bindingIntegrin beta-3Homo sapiens (human)
integrin bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin beta-3Homo sapiens (human)
coreceptor activityIntegrin beta-3Homo sapiens (human)
enzyme bindingIntegrin beta-3Homo sapiens (human)
identical protein bindingIntegrin beta-3Homo sapiens (human)
vascular endothelial growth factor receptor 2 bindingIntegrin beta-3Homo sapiens (human)
metal ion bindingIntegrin beta-3Homo sapiens (human)
cell adhesion molecule bindingIntegrin beta-3Homo sapiens (human)
extracellular matrix bindingIntegrin beta-3Homo sapiens (human)
fibrinogen bindingIntegrin beta-3Homo sapiens (human)
protein bindingIntegrin alpha-IIbHomo sapiens (human)
identical protein bindingIntegrin alpha-IIbHomo sapiens (human)
metal ion bindingIntegrin alpha-IIbHomo sapiens (human)
extracellular matrix bindingIntegrin alpha-IIbHomo sapiens (human)
molecular adaptor activityIntegrin alpha-IIbHomo sapiens (human)
fibrinogen bindingIntegrin alpha-IIbHomo sapiens (human)
integrin bindingIntegrin alpha-IIbHomo sapiens (human)
[Information is prepared from geneontology information from the June-17-2024 release]

Ceullar Components (30)

Processvia Protein(s)Taxonomy
glutamatergic synapseIntegrin beta-3Homo sapiens (human)
nucleusIntegrin beta-3Homo sapiens (human)
nucleoplasmIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin beta-3Homo sapiens (human)
cell-cell junctionIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
external side of plasma membraneIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
apical plasma membraneIntegrin beta-3Homo sapiens (human)
platelet alpha granule membraneIntegrin beta-3Homo sapiens (human)
lamellipodium membraneIntegrin beta-3Homo sapiens (human)
filopodium membraneIntegrin beta-3Homo sapiens (human)
microvillus membraneIntegrin beta-3Homo sapiens (human)
ruffle membraneIntegrin beta-3Homo sapiens (human)
integrin alphav-beta3 complexIntegrin beta-3Homo sapiens (human)
melanosomeIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
postsynaptic membraneIntegrin beta-3Homo sapiens (human)
extracellular exosomeIntegrin beta-3Homo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin beta-3Homo sapiens (human)
glycinergic synapseIntegrin beta-3Homo sapiens (human)
integrin complexIntegrin beta-3Homo sapiens (human)
protein-containing complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-PKCalpha complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-IGF-1-IGF1R complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-HMGB1 complexIntegrin beta-3Homo sapiens (human)
receptor complexIntegrin beta-3Homo sapiens (human)
alphav-beta3 integrin-vitronectin complexIntegrin beta-3Homo sapiens (human)
alpha9-beta1 integrin-ADAM8 complexIntegrin beta-3Homo sapiens (human)
focal adhesionIntegrin beta-3Homo sapiens (human)
cell surfaceIntegrin beta-3Homo sapiens (human)
synapseIntegrin beta-3Homo sapiens (human)
plasma membraneIntegrin alpha-IIbHomo sapiens (human)
focal adhesionIntegrin alpha-IIbHomo sapiens (human)
cell surfaceIntegrin alpha-IIbHomo sapiens (human)
platelet alpha granule membraneIntegrin alpha-IIbHomo sapiens (human)
extracellular exosomeIntegrin alpha-IIbHomo sapiens (human)
integrin alphaIIb-beta3 complexIntegrin alpha-IIbHomo sapiens (human)
blood microparticleIntegrin alpha-IIbHomo sapiens (human)
integrin complexIntegrin alpha-IIbHomo sapiens (human)
external side of plasma membraneIntegrin alpha-IIbHomo sapiens (human)
plasma membraneGamma-aminobutyric acid receptor subunit gamma-2Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit alpha-1Rattus norvegicus (Norway rat)
plasma membraneGamma-aminobutyric acid receptor subunit beta-2Rattus norvegicus (Norway rat)
[Information is prepared from geneontology information from the June-17-2024 release]

Bioassays (49)

Assay IDTitleYearJournalArticle
AID1129855Cytotoxicity against human HepG2 cells assessed as cell viability at 10.57 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129857Cytotoxicity against human HepG2 cells assessed as cell viability at 2.64 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129860Cytotoxicity against human HepG2 cells assessed as cell viability at 84.55 ug/ml after 4 hrs by trypan blue dye exclusion assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID338301Acaricidal activity against Psoroptes cuniculi at 3 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID338299Acaricidal activity against Psoroptes cuniculi at 0.125% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID338298Acaricidal activity against Psoroptes cuniculi at 0.25% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1129863Cytotoxicity against human HepG2 cells assessed as cell viability at 84.55 ug/ml after 4 hrs by AO/DAPI double staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129864Cytotoxicity against human HepG2 cells assessed as cell viability at 42.28 ug/ml after 4 hrs by AO/DAPI double staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129856Cytotoxicity against human HepG2 cells assessed as cell viability at 5.28 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129871Induction of early apoptosis in human HepG2 cells assessed as decrease mitochondrial membrane potential at 21.14 ug/ml after 4 hrs by JC-1 staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129868Genotoxicity in human HepG2 cells assessed as DNA strand-breakage at 21.14 ug/ml after 18 hrs by alkaline comet assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1103184Ratio of benzyl benzoate LD50 to compound LD50 for 7 to 10 day-old Dermatophagoides pteronyssinus adult after 24 hr by microscopy2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae).
AID1129866Genotoxicity in human HepG2 cells assessed as DNA strand-breakage at 84.55 ug/ml after 18 hrs by alkaline comet assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1103185Ratio of benzyl benzoate LD50 to compound LD50 for 7 to 10 day-old Dermatophagoides farinae adult after 24 hr by microscopy2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae).
AID1129861Cytotoxicity against human HepG2 cells assessed as cell viability at 42.28 ug/ml after 4 hrs by trypan blue dye exclusion assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID338300Acaricidal activity against Psoroptes cuniculi at 6 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1103188Acaricidal activity against 7 to 10 day-old Dermatophagoides farinae adult after 24 hr by microscopy2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae).
AID1129858Cytotoxicity against human HepG2 cells assessed as cell viability at 1.32 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129867Genotoxicity in human HepG2 cells assessed as DNA strand-breakage at 42.28 ug/ml after 18 hrs by alkaline comet assay2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129873Induction of late apoptosis in human HepG2 cells assessed as induction of DNA fragmentation at 42.28 ug/ml after 4 hrs by JC-1 staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129874Induction of late apoptosis in human HepG2 cells assessed as induction of DNA fragmentation at 21.14 ug/ml after 4 hrs by JC-1 staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129852Cytotoxicity against human HepG2 cells assessed as cell viability at 84.55 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID392785Inhibition of soybean 15-lipoxygenase2009Bioorganic & medicinal chemistry, Feb-15, Volume: 17, Issue:4
Design, synthesis and SAR studies of 4-allyoxyaniline amides as potent 15-lipoxygensae inhibitors.
AID1129869Induction of early apoptosis in human HepG2 cells assessed as decrease mitochondrial membrane potential at 84.55 ug/ml after 4 hrs by JC-1 staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID338302Acaricidal activity against Psoroptes cuniculi at 1 uL after 24 hrs by inhalation assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1129865Cytotoxicity against human HepG2 cells assessed as cell viability at 21.14 ug/ml after 4 hrs by AO/DAPI double staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129854Cytotoxicity against human HepG2 cells assessed as cell viability at 21.14 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1439501Nematocidal activity against Meloidogyne incognita2017European journal of medicinal chemistry, Mar-31, Volume: 129Medicinal plants used as anthelmintics: Ethnomedical, pharmacological, and phytochemical studies.
AID1129872Induction of late apoptosis in human HepG2 cells assessed as induction of DNA fragmentation at 84.55 ug/ml after 4 hrs by JC-1 staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129870Induction of early apoptosis in human HepG2 cells assessed as decrease mitochondrial membrane potential at 42.28 ug/ml after 4 hrs by JC-1 staining relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129862Cytotoxicity against human HepG2 cells assessed as cell viability at 21.14 ug/ml after 4 hrs by trypan blue dye exclusion assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID1129859Cytotoxicity against human HepG2 cells assessed as cell viability at 0.67 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID395274Inhibition of 15-lipoxygenase form soybean2009Bioorganic & medicinal chemistry, Mar-15, Volume: 17, Issue:6
Design and synthesis of 4-methoxyphenylacetic acid esters as 15-lipoxygenase inhibitors and SAR comparative studies of them.
AID1103187Acaricidal activity against 7 to 10 day-old Dermatophagoides pteronyssinus adult after 24 hr by microscopy2004Journal of agricultural and food chemistry, May-19, Volume: 52, Issue:10
Acaricidal activity of constituents identified in Foeniculum vulgare fruit oil against Dermatophagoides spp. (Acari: Pyroglyphidae).
AID338297Acaricidal activity against Psoroptes cuniculi at 1% dilution in physiological saline after 48 hrs by direct contact assay1995Journal of natural products, Aug, Volume: 58, Issue:8
Structure/activity relationship of some natural monoterpenes as acaricides against Psoroptes cuniculi.
AID1129853Cytotoxicity against human HepG2 cells assessed as cell viability at 42.28 ug/ml after 4 hrs by MTT assay relative to control2014Journal of natural products, Apr-25, Volume: 77, Issue:4
Investigation of the cytotoxic, genotoxic, and apoptosis-inducing effects of estragole isolated from fennel (Foeniculum vulgare).
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588497High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain F protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588501High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Lethal Factor Protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Current protocols in cytometry, Oct, Volume: Chapter 13Microsphere-based flow cytometry protease assays for use in protease activity detection and high-throughput screening.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2006Cytometry. Part A : the journal of the International Society for Analytical Cytology, May, Volume: 69, Issue:5
Microsphere-based protease assays and screening application for lethal factor and factor Xa.
AID588499High-throughput multiplex microsphere screening for inhibitors of toxin protease, specifically Botulinum neurotoxin light chain A protease, MLPCN compound set2010Assay and drug development technologies, Feb, Volume: 8, Issue:1
High-throughput multiplex flow cytometry screening for botulinum neurotoxin type a light chain protease inhibitors.
AID651635Viability Counterscreen for Primary qHTS for Inhibitors of ATXN expression
AID504812Inverse Agonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID504810Antagonists of the Thyroid Stimulating Hormone Receptor: HTS campaign2010Endocrinology, Jul, Volume: 151, Issue:7
A small molecule inverse agonist for the human thyroid-stimulating hormone receptor.
AID1745845Primary qHTS for Inhibitors of ATXN expression
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (175)

TimeframeStudies, This Drug (%)All Drugs %
pre-199015 (8.57)18.7374
1990's9 (5.14)18.2507
2000's40 (22.86)29.6817
2010's87 (49.71)24.3611
2020's24 (13.71)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 54.62

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index54.62 (24.57)
Research Supply Index5.23 (2.92)
Research Growth Index5.05 (4.65)
Search Engine Demand Index87.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (54.62)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews7 (3.78%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other178 (96.22%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]